Skip to main content
. Author manuscript; available in PMC: 2017 May 1.
Published in final edited form as: Psychoneuroendocrinology. 2016 Feb 3;67:133–141. doi: 10.1016/j.psyneuen.2016.01.024

Fig. 2.

Fig. 2

Covariate-adjusted associations between Lifetime PTSD and the distribution of T cell phenotypes among 85 participants in the Detroit Neighborhood Health Study. Abbreviations: PTSD, posttraumatic stress disorder; E:N ratio, ratio of end-stage non-proliferative effector cells (E; CCR7-CD45RA+CD27-CD28-orTEMRA) to naïve T-cells (N; CCR7+CD45RA+CD27+CD28 +).

*P value <0.05.

aModel 1: Association between PTSD and T-cell outcome adjusted for age, gender, race/ethnicity, and education.

bModel 2: Association between PTSD and T-cell outcome additionally adjusted for smoking status and medication use. 3 individuals missing data on medication use were excluded from the model.